Luluh Alhassan is a PhD researcher at UL since April 2019. Key areas of research include: Monitoring the pollutant level in the environment by developing high sensitive detection method. In addition, Luluh has an interest in using nanoparticles and optical microscopy as a novel tool to improve and control the detection of toxics material in the environment and human body.
In 2009, Luluh received her Bachelor Degree in Biology, Science and Education school, King Faisal University, Al-Ahsa, Saudi Arabia. In 2016, She received her master degree in animal environment and pollution, Department of Zoology, Faculty of Science, King Saud University, Riyadh, Saudi Arabia. During her masters, she worked as a teacher assistant in 2015/2016 at King Saud University.
Luluh has a sound expertise of the advance technologies and laboratory equipment that is most importantly needed in environmental management and Science experiments. Working as a demonstrator supervising undergraduate students.
2021 PMP certificate project management institution, England / 2016 Master’s degree of Science King Saud University, Saudi Arabia / 2009 Bachelor’s degree of Science and Education in Biology King Faisal University, Saudi Arabia.
- Siobhán O'Connor, Luluh Al Hassan, Grace Brennan, Kieran McCarthy, Christophe Silien, Ning Liu, Tadhg Kennedy, Kevin Ryan, Emmet O'Reilly. Cadmium selenide sulfide quantum dots with tuneable emission profiles: An electrochemiluminescence platform for the determination of TIMP-1 protein. Bioelectrochemistry, 2022. 148: p. 108221
- Pritam Khan, Grace Brennan, Zhe Li, Luluh Al Hassan, Daragh Rice, Matthew Gleeson, Aladin A. Mani, Syed A. M. Tofail, Hongxing Xu, Ning Liu, and Christophe Silien. Circular Polarization Conversion in Single Plasmonic Spherical Particles. Nano Letters, 2022. 22(4): p. 1504-1510
- Patent in Synthesis of Hesperetin Nanoparticles. Docket No. US 9,700,512 B1, The United States Patent and Trademark Office (USPTO), 600 Dulany St, Alexandria, VA 22314, U.S. July 11, 2017
- Patent in Synthesis of Naringenin Nanoparticles. Docket No. US 9,622,984 B1, The United States Patent and Trademark Office (USPTO), 600 Dulany St, Alexandria, VA 22314, U.S. April 18, 2017